Publication:
Effect of carbamazepine therapy on erythrocyte and plasma antioxidant levels in children with benign partial epilepsy

dc.contributor.authorsYalcin, AD; Kisadere, G; Guzel, O; Yalcin, AS
dc.date.accessioned2022-03-12T16:56:26Z
dc.date.accessioned2026-01-11T18:30:07Z
dc.date.available2022-03-12T16:56:26Z
dc.date.issued1996
dc.description.abstractThe brain mechanisms underlying epilepsy are not completely understood, although there is evidence that there is increased lipid peroxidation in neurological diseases. There also appears to be a membrane abnormality in epilepsy. Carbamazepine (CBZ) therapy in epileptic children with benign partial epilepsy has significantly increased osmotic fragility and lipid peroxidation of their red blood cells (RBC). The present study suggests that long-term CBZ treatment may induce oxidative stress in the RBC which results in a compensatory response in antioxidant enzymes.
dc.identifier.doidoiWOS:A1996UK07100004
dc.identifier.issn0269-8951
dc.identifier.urihttps://hdl.handle.net/11424/226760
dc.identifier.wosWOS:A1996UK07100004
dc.language.isoeng
dc.publisherCHAPMAN HALL LTD
dc.relation.ispartofMEDICAL SCIENCE RESEARCH
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectantioxidants
dc.subjectcarbamazepine
dc.subjectepilepsy
dc.subjecterythrocyte
dc.subjectplasma
dc.subjectantioxidant
dc.subjectTISSUE SAMPLES
dc.subjectRADICALS
dc.subjectACID
dc.titleEffect of carbamazepine therapy on erythrocyte and plasma antioxidant levels in children with benign partial epilepsy
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage224
oaire.citation.issue4
oaire.citation.startPage223
oaire.citation.titleMEDICAL SCIENCE RESEARCH
oaire.citation.volume24

Files